Skip to main content

Table 2 Correlations between TGF-β1, PDGF and proBNP

From: Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer

 

TGF-β1 before RT

TGF-β1 after RT

TGF-β1

3 years

Change in TGF-β1 before RT–after RT

Change in TGF-β1 before RT–3 years

Change in TGF-β1 after RT–3 years

PDGF before RT

0.667

0.222

0.132

─0.405

─0.480

─0.088

PDGF after RT

0.453

0.713

0.316

0.249

─0.141

─0.361

PDGF 3 years

0.299

0.338

0.749

0.022

0.336

0.414

Change in PDGF before RT–after RT

─0.221

0.481

0.246

0.646

0.363

─0.204

Change in PDGF before RT–3 years

0.254

─0.128

0.625

0.308

0.739

0.513

Change in PDGF after RT–3 years

─0.132

─0.267

0.544

─0.152

0.600

0.826

proBNP before RT

0.298

─0.037

─0.040

0.325

0.280

─0.050

proBNP after RT

0.265

─0.041

─0.006

0.252

─0.183

─0.005

proBNP 3 years

0.293

─0.060

─0.061

0.321

0.297

─0.070

Change in proBNP before RT–after RT

─0.040

─0.016

0.054

0.101

0.150

0.075

Change in proBNP before RT–3 years

0.114

0.087

0.004

─0.023

─0.111

─0.129

Change in proBNP after RT–3 years

0.212

0.018

0.004

0.259

─0.232

─0.060

  1. TGF-β1 transforming growth factor beta 1, PDGF Platelet-derived growth factor, proBNP N-terminal pro-brain natriuretic peptide, RT Radiotherapy, Correlation coefficients (Spearman’s rho) in bold are statistically significant (p < 0.05)